MedTrace Logo

Post-Operative Physical Activity Monitoring: Algorithm Performance and Clinical Outcomes

NCT06605066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-07-24

No results posted yet for this study

Summary

The goal of this observational study is to validate physical activity algorithms in post-operative populations through raw accelerometer data collection using the ADI Study Watch 4.5 while in an in-patient setting. The secondary objective of the study is to collect skin temperature, photoplethysmography \[PPG\], Bioimpedance Analysis \[BIA\], heart rate \[HR\], SpO2, and electrodermal activity \[EDA\] using the ADI Study Watch 4.5. The main questions it aims to answer are:

* Can a wearable physical activity monitoring device assess patients\' activity levels with higher accuracy and precision compared to traditional physical activity monitoring methods during the post-operative period?
* Do wearable devices placed on different body regions perform similarly in tracking physical activity during the post-operative period?
* Do post-operative physical activity monitoring algorithms improve patient compliance, accelerate recovery, and reduce hospital stay duration?
* Analysis of the activity tracking performance of a consumer device (Apple Watch) in patients after cardiac and thoracic surgery.

Conditions

  • Postoperative Period
  • Physical Activity
  • Wearable Electronic Devices
  • Algorithms
  • Thoracic Surgery
  • Cardiac Surgery

Sponsors & Collaborators

  • Analog Device, Inc.

    collaborator OTHER

  • Alp Ozel

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-09
Primary Completion
2025-07-21
Completion
2025-07-21

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06605066 on ClinicalTrials.gov